{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-052778","form_type":"8-K","ticker":"IRMD","cik":"0001325618","company_name":"IRADIMED CORP","filed_at":"2022-04-29T23:59:59+00:00","discovered_at":"2026-05-14T18:04:00.216391+00:00","generated_at":"2026-06-26T02:30:44.977108+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"iRadimed Q1 revenue $12.3M (+33% YoY), EPS $0.20; raises FY22 guidance","bullets":["Q1 revenue $12.3M vs $9.2M YoY; GAAP diluted EPS $0.20 vs $0.11; non-GAAP EPS $0.22 vs $0.13.","Raised FY22 guidance: revenue $52.5-53.2M (prev $51.4-52.2M), GAAP EPS $0.89-0.95, non-GAAP EPS $0.96-1.03.","Q2 guidance: revenue $12.5-12.7M, GAAP EPS $0.21-0.23, non-GAAP EPS $0.23-0.25.","Paid special dividend of $1.00 per share during Q1 2022; monitors segment revenue surged to $5.19M from $2.60M YoY."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-052778","json":"https://secwatch.observer/filing/0001104659-22-052778.json","markdown":"https://secwatch.observer/filing/0001104659-22-052778.md","text":"https://secwatch.observer/filing/0001104659-22-052778.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1325618/000110465922052778/0001104659-22-052778-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1325618/000110465922052778/tm2213916d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T02:30:44.977108+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}